Tags » Pulmonary Embolism

FDA Approves Dabigatran For Reduction of Risk and Recurrence of deep venous thrombosis and pulmonary embolism

The U.S. Food and Drug Administration (FDA) has approved the anticoagulant dabigatran (Pradaxa) “for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated,” according to a press release from Boehringer Ingelheim Pharmaceuticals, Inc. 360 more words


PEITHO Trial Teaches an Important Lesson

The current issue of the New England Journal of Medicine contains an important trial- the PEITHO trial. Its important because it tells us what not to do. 302 more words

Evidence Based Practice

This Just In: Bill Pulmonary Embolisms are More Popular Than Regular Pulmonary Embolisms

That’s right! Victims of both types of pulmonary embolisms reported enjoying the symptoms of their Bill Pulmonary Embolism more than the life threatening kind! Proof that Bill Pulmonary Embolisms are more popular than regular run-of-mill pulmonary embolisms. 16 more words

Dying To Have A Big Butt??

Ladies, what is going on with the phenomenon of having a big butt? People are literally DYING after the procedure.  Is it really worth it??? NO is the answer.   87 more words


Syncope, desaturation and ECG changes = diagnosis (post # 73)

Syncope, desaturation and ECG changes = diagnosis (post # 73)

Adult patient came in due to syncope and cannot recall event.Initial saturation at room air is 83% increased to 93% at 6L/min. 557 more words

Pulmonary Embolism

S1Q3T3 pattern (post # 61)

S1Q3T3 pattern (post # 61)

A patient developed suddent onset of dyspnea and desaturation after surgery. The S1Q3T3 pattern is marked. Pulmonary embolism (PE) was documented. 72 more words